[HTML][HTML] The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human …

RMLC Biancatelli, PA Solopov… - … of Physiology-Lung …, 2021 - journals.physiology.org
Acute lung injury (ALI) leading to acute respiratory distress syndrome is the major cause of
COVID-19 lethality. Cell entry of SARS-CoV-2 occurs via the interaction between its surface …

SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signalling

L Perico, M Morigi, A Pezzotta, M Locatelli, B Imberti… - Scientific Reports, 2023 - nature.com
The spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can
interact with endothelial cells. However, no studies demonstrated the direct effect of the …

[HTML][HTML] SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells

YJ Suzuki, SI Nikolaienko, VA Dibrova, YV Dibrova… - Vascular …, 2021 - Elsevier
Currently, the world is suffering from the pandemic of coronavirus disease 2019 (COVID-19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that uses …

The SARS-CoV-2 S1 spike protein promotes MAPK and NF-kB activation in human lung cells and inflammatory cytokine production in human lung and intestinal …

CB Forsyth, L Zhang, A Bhushan, B Swanson, L Zhang… - Microorganisms, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic began in January 2020 in Wuhan,
China, with a new coronavirus designated SARS-CoV-2. The principal cause of death from …

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

AC Montezano, LL Camargo, S Mary, KB Neves… - Scientific Reports, 2023 - nature.com
Abstract COVID-19, caused by SARS-CoV-2, is a respiratory disease associated with
inflammation and endotheliitis. Mechanisms underling inflammatory processes are unclear …

SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2

Y Lei, J Zhang, CR Schiavon, M He, L Chen… - Circulation …, 2021 - Am Heart Assoc
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection relies on the
binding of S protein (Spike glycoprotein) to ACE (angiotensinconverting enzyme) 2 in the …

[HTML][HTML] SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages

K Shirato, T Kizaki - Heliyon, 2021 - cell.com
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now spread globally. Some …

SARS-CoV-2 spike protein suppresses ACE2 and type I interferon expression in primary cells from macaque lung bronchoalveolar lavage

Y Sui, J Li, DJ Venzon, JA Berzofsky - Frontiers in Immunology, 2021 - frontiersin.org
SARS-CoV-2 virus causes upper and lower respiratory diseases including pneumonia, and
in some cases, leads to lethal pulmonary failure. Angiotensin converting enzyme-2 (ACE2) …

Endothelial cell activation by SARS-CoV-2 spike S1 protein: a crosstalk between endothelium and innate immune cells

BM Rotoli, A Barilli, R Visigalli, F Ferrari, V Dall'Asta - Biomedicines, 2021 - mdpi.com
Background. Emerging evidences suggest that in severe COVID-19, multi-organ failure is
associated with a hyperinflammatory state (the so-called “cytokine storm”) in combination …

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

S Khan, MS Shafiei, C Longoria, JW Schoggins… - Elife, 2021 - elifesciences.org
The pathogenesis of COVID-19 is associated with a hyperinflammatory response; however,
the precise mechanism of SARS-CoV-2-induced inflammation is poorly understood. Here …